Skip to main content
Top
Published in: European Journal of Clinical Microbiology & Infectious Diseases 2/2013

01-02-2013 | Article

Standard Nutrient Agar 1 as a substitute for blood-supplemented Müller–Hinton agar for antibiograms in developing countries

Authors: N. Niederstebruch, D. Sixt

Published in: European Journal of Clinical Microbiology & Infectious Diseases | Issue 2/2013

Login to get access

Abstract

In the industrial world, the agar diffusion test is a standard procedure for the susceptibility testing of bacteria isolates. Beta-hemolytic Streptococcus spp. are tested with Müller–Hinton agar supplemented with 5 % blood, a so-called blood agar. The results are interpreted using standardized tables, which only exist for this type of nutrient matrix. Because of a number difficulties, both with respect to technical issues and to manual skills, blood agar is not a feasible option in many developing countries. Beta-hemolytic Streptococcus spp. also grow on Standard Nutrient Agar 1 (StNA1). This suggests using that type of nutrient medium for running agar diffusion tests. However, there are no standardized tables that can be used for interpreting the diameters of the zones of inhibition on StNA1 1. Using the existing standardized tables for blood agar to interpret cultures on StNA1 1 would be of great benefit under such circumstances where blood agar is not available. With this in mind, we conducted comparative tests to evaluate the growth characteristics of beta-hemolytic Streptococcus spp. on StNA1 1 compared to Müller–Hinton agar supplemented with 5 % sheep blood. In this study, we were able to show that beta-hemolytic Streptococcus spp. develop similar zones of inhibition on blood agar and on StNA1 1. Therefore, it is suggested that, for the interpretation of antibiograms of beta-hemolytic Streptococcus spp. performed on StNA1 1, the standard tables for blood agar can be used.
Appendix
Available only for authorised users
Footnotes
1
CIP is not recommended for treating beta-hemolytic Streptococcus spp., but in this study, we analyzed and compared the growth behavior of these bacteria, not their resistances. For this reason, we decided to check also an antibiotic not common for treating beta-hemolytic Streptococcus spp.
 
Literature
1.
go back to reference bioMérieux (2002) Product data sheet: 11378 A – DE – 2002/07. Columbia Agar + 5 % Hammelblut (COS) – REF 43041/43049 bioMérieux (2002) Product data sheet: 11378 A – DE – 2002/07. Columbia Agar + 5 % Hammelblut (COS) – REF 43041/43049
2.
go back to reference bioMérieux (2004) Product data sheet: 11677 B – DE – 2004/05. Mueller Hinton Agar + 5 % Schafblut (MHS) – REF 43321/43329 bioMérieux (2004) Product data sheet: 11677 B – DE – 2004/05. Mueller Hinton Agar + 5 % Schafblut (MHS) – REF 43321/43329
5.
go back to reference Jorgensen JH, Swenson JM, Tenover FC, Ferraro MJ, Hindler JA, Murray PR (1994) Development of interpretive criteria and quality control limits for broth microdilution and disk diffusion antimicrobial susceptibility testing of Streptococcus pneumoniae. J Clin Microbiol 32(10):2448–2459PubMed Jorgensen JH, Swenson JM, Tenover FC, Ferraro MJ, Hindler JA, Murray PR (1994) Development of interpretive criteria and quality control limits for broth microdilution and disk diffusion antimicrobial susceptibility testing of Streptococcus pneumoniae. J Clin Microbiol 32(10):2448–2459PubMed
6.
go back to reference Korgenski EK, Daly JA (1998) Evaluation of the BIOMIC video reader system for determining interpretive categories of isolates on the basis of disk diffusion susceptibility results. J Clin Microbiol 36(1):302–304PubMed Korgenski EK, Daly JA (1998) Evaluation of the BIOMIC video reader system for determining interpretive categories of isolates on the basis of disk diffusion susceptibility results. J Clin Microbiol 36(1):302–304PubMed
7.
go back to reference Muhammad G, Hoblet KH, Bech-Nielsen S, Jackwood DL, Smith KL (1998) Reproducibility of antibiogram of bovine mammary gland staphylococci under conditions of repeated subculturing. Zentralbl Veterinarmed B 45(3):189–192PubMed Muhammad G, Hoblet KH, Bech-Nielsen S, Jackwood DL, Smith KL (1998) Reproducibility of antibiogram of bovine mammary gland staphylococci under conditions of repeated subculturing. Zentralbl Veterinarmed B 45(3):189–192PubMed
8.
go back to reference Russell FM, Biribo SSN, Selvaraj G, Oppedisano F, Warren S, Seduadua A, Mulholland EK, Carapetis JR (2006) As a bacterial culture medium, citrated sheep blood agar is a practical alternative to citrated human blood agar in laboratories of developing countries. J Clin Microbiol 44(9):3346–3351PubMedCrossRef Russell FM, Biribo SSN, Selvaraj G, Oppedisano F, Warren S, Seduadua A, Mulholland EK, Carapetis JR (2006) As a bacterial culture medium, citrated sheep blood agar is a practical alternative to citrated human blood agar in laboratories of developing countries. J Clin Microbiol 44(9):3346–3351PubMedCrossRef
9.
go back to reference Thorvilson J, Kohner P, Henry N, Cockerill F 3rd (1997) Comparison of agar dilution, broth dilution, disk diffusion, and the E-test for susceptibility testing of penicillin-susceptible and penicillin-resistant Streptococcus pneumoniae. Eur J Clin Microbiol Infect Dis 16(5):391–394PubMedCrossRef Thorvilson J, Kohner P, Henry N, Cockerill F 3rd (1997) Comparison of agar dilution, broth dilution, disk diffusion, and the E-test for susceptibility testing of penicillin-susceptible and penicillin-resistant Streptococcus pneumoniae. Eur J Clin Microbiol Infect Dis 16(5):391–394PubMedCrossRef
Metadata
Title
Standard Nutrient Agar 1 as a substitute for blood-supplemented Müller–Hinton agar for antibiograms in developing countries
Authors
N. Niederstebruch
D. Sixt
Publication date
01-02-2013
Publisher
Springer-Verlag
Published in
European Journal of Clinical Microbiology & Infectious Diseases / Issue 2/2013
Print ISSN: 0934-9723
Electronic ISSN: 1435-4373
DOI
https://doi.org/10.1007/s10096-012-1735-2

Other articles of this Issue 2/2013

European Journal of Clinical Microbiology & Infectious Diseases 2/2013 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.